£
Donate

We're here for you if you want to talk

0808 2080 888

[email protected]

We're funding 13 research projects across multiple blood cancers

14th Apr 2022

We're delighted to announce funding for 13 new research projects worth over £3million. These 13 research projects add to our overall portfolio of 82 research projects across 27 different institutions in the UK. Each of the projects will focus on a key theme in blood cancer over the next three years.

Our new research projects

🧪 Professor Ian Hitchcock from the University of York wants to understand more about how myeloproliferative neoplasm (MPN) develops to find out whether there might be a way to stop it from happening.

Find out more🔎

🧪Dr Goedele Maertens from Imperial College London wants to understand how a virus can cause a rare type of lymphoma to try and find new targets for treatment.

Find out more🔎

🧪Professor Alex Tonks from Cardiff University is studying what drives acute myeloid leukaemia (AML) to try and find new treatment targets for people the disease.

Find out more🔎

🧪Dr Pramila Krishnamurthy from King's College London wants to understand how the level of chemotherapy people with myelodysplastic syndrome (MDS) receive can affect their quality of life.

Find out more🔎

🧪Dr Daniel Hodson from the University of Cambridge is looking for new ways to treat non-Hodgkin lymphoma. He wants to find ways to treat people in a kinder way, with fewer side effects.

Find out more🔎

🧪Dr Robbert Hoogeboom from King's College London wants to know more about how chronic lymphocytic leukaemia (CLL) cells move around the body and start growing.

Find out more🔎

🧪Professor Claire Edwards from the University of Oxford will look at how fat cells are involved in myeloma progressing as she thinks that fat cells wake up cancer cells and cause the disease to return.

Find out more🔎

🧪Dr Ingo Ringshausen from the University of Cambridge wants to understand more about how CLL cells can resist treatment as he thinks some cells manage to escape chemotherapy, causing the disease to return.

Find out more🔎

🧪Professor Dominique Bonnet from the Francis Crick Institute wants to understand more about a cell that she thinks is responsible for AML returning.

Find out more🔎

🧪Dr Michele Mishto from King's College London wants to understand whether we might be able to harness our immune system to treat MPN.

Find out more🔎

🧪Professor Anthony Moorman from Newcastle University is trying to find markers that can tell clinicians how much treatment someone with acute lymphoblastic leukaemia (ALL) needs.

Find out more🔎

🧪Professor Ming-Qing Du from the University of Cambridge will try and work out how MALT lymphoma develops to try and find new ways to treat it.

Find out more🔎

🧪Dr Dinis Calado from the Francis Crick Institute will try and understand more about why some types of diffuse large B cell lymphoma (DLBCL) stop responding to treatment.

Find out more🔎

None of this would be possible without your generous support, thank you

Sign up to our newsletter

Get the latest news from Blood Cancer UK directly to your inbox

An error occured. Please try again later.

We will keep you updated about our work and the ways you can help, including campaigns and events. We promise to respect your privacy and we will never sell or swap your details.